As of May 29
| +0.12 / +0.36%|
The 2 analysts offering 12-month price forecasts for Bio-Reference Laboratories Inc have a median target of 35.00, with a high estimate of 38.00 and a low estimate of 32.00. The median estimate represents a +5.36% increase from the last price of 33.22.
The current consensus among 3 polled investment analysts is to Hold stock in Bio-Reference Laboratories Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.